lorazepam has been researched along with gabapentin in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (9.52) | 18.2507 |
| 2000's | 6 (28.57) | 29.6817 |
| 2010's | 8 (38.10) | 24.3611 |
| 2020's | 5 (23.81) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Krahn, LE; Reeves, AL; Sharbrough, FW; So, EL | 1 |
| Hildebrandt, J; Paulus, W; Tergau, F; Wischer, S; Ziemann, U | 1 |
| Brouns, R; Van Paesschen, W | 1 |
| Hemphill, JC; Hwang, W; Marco, E; Ralph, J | 1 |
| Boyle, E; Malcolm, R; Myrick, LH; Randall, PK; Veatch, LM | 1 |
| Anton, RF; Becker, HC; Boyle, E; Malcolm, R; Myrick, H; Randall, CL; Randall, PK | 1 |
| Jagsch, C; Kierner, KA; Watzke, HH | 1 |
| Kenedi, C; West, S | 1 |
| Gandhi, RA; Nair, AG; Shah, BR | 1 |
| Brunkhorst, J; Carter, BS | 1 |
| Burak, M; Morrison, M; Udeh, E | 1 |
| Andaluz, A; Atem, F; Bakre, S; Blair, S; Claassen, C; DeMoss, D; Hsu, J; Khan, M; Rush, AJ | 1 |
| Hayashi, T; Noguchi, Y; Tachi, T; Takaoka, M; Teramachi, H | 1 |
| Barnett, ML; Bykov, K; Gagne, JJ; Glynn, RJ; Khan, NF | 1 |
| Hume, AL; Lawal, OD; Meador, KJ; Wen, X | 1 |
| Guo, D; Kossintseva, I; Zloty, DM | 1 |
3 review(s) available for lorazepam and gabapentin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Strategies to prevent the neuropsychiatric side-effects of corticosteroids: a case report and review of the literature.
Topics: Adult; Amines; Benzodiazepines; Cyclohexanecarboxylic Acids; Drug Therapy, Combination; Female; Gabapentin; gamma-Aminobutyric Acid; Glucocorticoids; Granulomatosis with Polyangiitis; Humans; Lithium Compounds; Lorazepam; Methylprednisolone; Olanzapine; Polyarteritis Nodosa; Prednisone; Psychoses, Substance-Induced | 2014 |
Neonatal pain management.
Topics: Amines; Analgesics, Opioid; Anti-Anxiety Agents; Barbiturates; Chronic Pain; Cyclohexanecarboxylic Acids; Dexmedetomidine; Gabapentin; gamma-Aminobutyric Acid; Humans; Hypnotics and Sedatives; Infant, Newborn; Intensive Care Units, Neonatal; Kangaroo-Mother Care Method; Ketamine; Lorazepam; Midazolam; Neonatal Abstinence Syndrome; Pain Management; Pain Measurement; Palliative Care; Propofol; Sucking Behavior; Sucrose; Terminal Care | 2017 |
4 trial(s) available for lorazepam and gabapentin
| Article | Year |
|---|---|
Pharmacological control of facilitatory I-wave interaction in the human motor cortex. A paired transcranial magnetic stimulation study.
Topics: Acetates; Adult; Amines; Anticonvulsants; Carbamazepine; Central Nervous System Depressants; Cyclohexanecarboxylic Acids; Electric Stimulation; Ethanol; Evoked Potentials, Motor; Female; Gabapentin; gamma-Aminobutyric Acid; Humans; Lamotrigine; Lorazepam; Male; Motor Cortex; Neural Inhibition; Phenobarbital; Transcranial Magnetic Stimulation; Triazines; Vigabatrin | 1998 |
Self-reported sleep, sleepiness, and repeated alcohol withdrawals: a randomized, double blind, controlled comparison of lorazepam vs gabapentin.
Topics: Adult; Aged; Alcoholism; Amines; Cyclohexanecarboxylic Acids; Disorders of Excessive Somnolence; Double-Blind Method; Ethanol; Female; GABA Modulators; Gabapentin; gamma-Aminobutyric Acid; Humans; Lorazepam; Male; Middle Aged; Severity of Illness Index; Substance Withdrawal Syndrome; Surveys and Questionnaires | 2007 |
A double-blind trial of gabapentin versus lorazepam in the treatment of alcohol withdrawal.
Topics: Adult; Alcohol Drinking; Amines; Cyclohexanecarboxylic Acids; Dose-Response Relationship, Drug; Double-Blind Method; Excitatory Amino Acid Antagonists; Female; Gabapentin; gamma-Aminobutyric Acid; Humans; Hypnotics and Sedatives; Lorazepam; Male; Psychiatric Status Rating Scales; Recurrence; Substance Withdrawal Syndrome; Treatment Outcome | 2009 |
Efficacy and Safety of Anxiolytics in Mohs Micrographic Surgery: A Randomized, Double-Blinded, Placebo-Controlled Trial.
Topics: Alprazolam; Anti-Anxiety Agents; Anxiety; Diazepam; Double-Blind Method; Gabapentin; Humans; Lorazepam; Melatonin; Mohs Surgery; Pregabalin | 2023 |
14 other study(ies) available for lorazepam and gabapentin
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility | 2010 |
Movement disorders associated with the use of gabapentin.
Topics: Acetates; Adult; Amines; Anticonvulsants; Benzodiazepines; Cyclohexanecarboxylic Acids; Dyskinesia, Drug-Induced; Dystonia; Epilepsy; Female; Gabapentin; gamma-Aminobutyric Acid; Humans; Lorazepam; Male; Myoclonus; Ocular Motility Disorders | 1996 |
Recurrent complex partial status epilepticus associated with tiagabine rechallenge.
Topics: Acetates; Adult; Amines; Anticonvulsants; Carbamazepine; Cyclohexanecarboxylic Acids; Dose-Response Relationship, Drug; Drug Therapy, Combination; Epilepsy, Temporal Lobe; Gabapentin; gamma-Aminobutyric Acid; Hippocampus; Humans; Lorazepam; Male; Meningoencephalitis; Nipecotic Acids; Status Epilepticus; Tiagabine; Treatment Outcome | 2002 |
Incomplete Brown-Séquard syndrome after methamphetamine injection into the neck.
Topics: Acetates; Adult; Amines; Brown-Sequard Syndrome; Causalgia; Cyclohexanecarboxylic Acids; Gabapentin; gamma-Aminobutyric Acid; Humans; Infarction; Injections; Lorazepam; Male; Methamphetamine; Morphine; Neck; Sclerosing Solutions; Spinal Cord; Spinal Cord Injuries; Spinal Cord Ischemia; Substance Abuse, Intravenous; Vasoconstrictor Agents | 2003 |
Reversible delirium in an advanced cancer patient.
Topics: Amines; Analgesics; Analgesics, Opioid; Bone Neoplasms; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Carcinoma, Lobular; Cyclohexanecarboxylic Acids; Delirium; Disease Progression; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Gabapentin; gamma-Aminobutyric Acid; Humans; Lorazepam; Midazolam; Middle Aged; Neoplasm Staging; Neoplasms, Multiple Primary; Palliative Care; Spinal Neoplasms | 2012 |
Seeing the unseen: Charles Bonnet syndrome revisited.
Topics: Aged; Amines; Awareness; Cyclohexanecarboxylic Acids; Female; Gabapentin; gamma-Aminobutyric Acid; Hallucinations; Humans; Lorazepam; Macular Degeneration; Magnetic Resonance Imaging; Male; Syndrome; Treatment Outcome; Vision Disorders | 2015 |
Retrospective analysis of a gabapentin high dose taper compared to lorazepam in acute inpatient alcohol withdrawal.
Topics: Acute Disease; Adult; Alcoholism; Electronic Health Records; Endpoint Determination; Female; GABA Agents; Gabapentin; Humans; Hypnotics and Sedatives; Inpatients; Length of Stay; Lorazepam; Male; Middle Aged; Retrospective Studies; Substance Withdrawal Syndrome | 2019 |
Fixed-dose gabapentin augmentation in the treatment of alcohol withdrawal syndrome: a retrospective, open-label study.
Topics: Adult; Alcoholism; Benzodiazepines; Drug Tapering; Female; Gabapentin; Humans; Lorazepam; Male; Middle Aged; Outcome Assessment, Health Care; Retrospective Studies; Substance Withdrawal Syndrome; United States | 2020 |
Antiepileptic combination therapy with Stevens-Johnson syndrome and toxic epidermal necrolysis: Analysis of a Japanese pharmacovigilance database.
Topics: Anticonvulsants; Carbamazepine; Clobazam; Clonazepam; Databases, Factual; Drug Therapy, Combination; Epilepsy; Gabapentin; Humans; Japan; Lacosamide; Lamotrigine; Levetiracetam; Lorazepam; Pharmacovigilance; Phenytoin; Stevens-Johnson Syndrome; Valproic Acid | 2020 |
Coprescription of Opioids With Other Medications and Risk of Opioid Overdose.
Topics: Adult; Aged; Analgesics, Opioid; Baclofen; Benzodiazepines; Drug Interactions; Emergency Service, Hospital; Excitatory Amino Acid Antagonists; Female; Gabapentin; Hospitalization; Humans; Hypnotics and Sedatives; Lorazepam; Male; Middle Aged; Muscle Relaxants, Central; Opiate Overdose; Risk Factors | 2021 |
Utilization of Antiseizure Medications in Women of Childbearing Age With Epilepsy and Nonepilepsy Indications: A Retrospective Cohort Study.
Topics: Anticonvulsants; Clonazepam; Diazepam; Epilepsy; Female; Gabapentin; Humans; Lamotrigine; Lorazepam; Retrospective Studies; Topiramate; Valproic Acid | 2023 |